Lilly Del Caribe, Inc.
Plant certified by the Brazilian health regulator (ANVISA)
ANVISA, the Brazilian health regulator, holds a valid Good Manufacturing Practice certificate for this plant, covering biological active pharmaceutical ingredients, valid until 2027-10-16. The certificate is issued after an inspection of the plant itself, which is why a foreign regulator names this site: goods made here are allowed on the Brazilian market. Process number 25351104134201713.
- Type
- brand seeking distribution
- Location
- Puerto Rico
- Categories
- 药品制造
- Markets
- 波多黎各, 巴西
Listed in a source registry
Verified facts
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- debarment-clear (green), checked 2026-09-02 OpenSanctions
- sanctions-clear (green), checked 2026-09-02 OpenSanctions
- facility-registered (green), checked 2026-09-02 US EPA Facility Registry Service
Import rules for these goods
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)